These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 16446417)
1. The promise and predicament of cosmetic neurology. Chatterjee A J Med Ethics; 2006 Feb; 32(2):110-3. PubMed ID: 16446417 [TBL] [Abstract][Full Text] [Related]
2. When the boss turns pusher: a proposal for employee protections in the age of cosmetic neurology. Appel JM J Med Ethics; 2008 Aug; 34(8):616-8. PubMed ID: 18667652 [TBL] [Abstract][Full Text] [Related]
3. Measurement and interpretation of changes in memory in response to drug treatments. Weingartner H; Eckardt M; Molchan S; Sunderland T; Wolkowitz O Psychopharmacol Bull; 1992; 28(4):331-40. PubMed ID: 1296214 [TBL] [Abstract][Full Text] [Related]
4. Some ethical problems in psychiatry. Blomquist CD Ethics Sci Med; 1979; 6(2):105-14. PubMed ID: 477653 [No Abstract] [Full Text] [Related]
5. [Problems of modern psychopharmacology]. Kapor G Neuropsihijatrija; 1964; 12(1-4):19-25. PubMed ID: 16305151 [No Abstract] [Full Text] [Related]
6. Psychopharmacology in the mentally retarded and a few related issues. Gualtieri CT; Keppel JM Psychopharmacol Bull; 1985; 21(2):304-9. PubMed ID: 2860694 [No Abstract] [Full Text] [Related]
7. General provisions of the Convention. Gadd EM J Int Bioethique; 2001 Mar; 12(1):21-8. PubMed ID: 12174852 [No Abstract] [Full Text] [Related]
9. Just treat, or enhance? Kennedy D Science; 2004 Apr; 304(5667):17. PubMed ID: 15060288 [No Abstract] [Full Text] [Related]
10. Transcranial magnetic stimulation, deep brain stimulation and personal identity: ethical questions, and neuroethical approaches for medical practice. Jotterand F; Giordano J Int Rev Psychiatry; 2011 Oct; 23(5):476-85. PubMed ID: 22200137 [TBL] [Abstract][Full Text] [Related]
11. If Buddha were in treatment. Green A J Clin Psychiatry; 2007 Jul; 68(7):1150; author reply 1150. PubMed ID: 17685762 [No Abstract] [Full Text] [Related]
12. [Parenthood as a (new) challenge for psychiatric services]. Krumm S; Becker T Psychiatr Prax; 2011 Jan; 38(1):1-3. PubMed ID: 21181632 [No Abstract] [Full Text] [Related]
13. [Ethical issues of the research with psychiatric drugs]. Rego MP Cien Saude Colet; 2011 Apr; 16(4):2045-6; author reply 2048-9. PubMed ID: 21735760 [No Abstract] [Full Text] [Related]
14. Smart drugs for cognitive enhancement: ethical and pragmatic considerations in the era of cosmetic neurology. Cakic V J Med Ethics; 2009 Oct; 35(10):611-5. PubMed ID: 19793941 [TBL] [Abstract][Full Text] [Related]
15. Bioethics: looking forward and looking back. Rhodes R Am J Bioeth; 2013; 13(1):13-6. PubMed ID: 23311833 [No Abstract] [Full Text] [Related]
17. Pharmacoepidemiology of psychotropic drugs: examples of current research challenges on major public health issues. Verdoux H; Tournier M; Bégaud B Epidemiol Psichiatr Soc; 2009; 18(2):107-13. PubMed ID: 19526741 [TBL] [Abstract][Full Text] [Related]
18. [Complications of psychotropic drugs in the aged]. Audoly P; Dujardin P; Kretzschmar JF Ann Med Interne (Paris); 1976 AUG-SEP; 127(8-9):677-80. PubMed ID: 1008395 [No Abstract] [Full Text] [Related]
19. Autonomy and authenticity of enhanced personality traits. Bublitz JC; Merkel R Bioethics; 2009 Jul; 23(6):360-74. PubMed ID: 19527264 [TBL] [Abstract][Full Text] [Related]
20. [Autonomy attitudes in the treatment compliance of a cohort of subjects with continuous psychotropic drug administration]. Baumann M; Trincard M Encephale; 2002; 28(5 Pt 1):389-96. PubMed ID: 12386539 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]